Skinbetter Science was formed in 2016 to establish a new biotech-based paradigm in skincare. Our innovative approach is built on three pillars: a technology pipeline of scientific innovation across multiple skincare categories, rigorous clinical substantiation of the safety and efficacy of the products developed from these novel technologies, and a partnership with dermatologists, plastic surgeons, and other healthcare professionals in the aesthetic medical community to deliver best-in-class skincare solutions to their patients.

Prior to founding skinbetter science, our founders developed and refined a biotech-driven aesthetic philosophy through decades of experience building Medicis Pharmaceutical Corporation. From 1998 to 2012, Medicis grew into one of the world’s leading specialty pharmaceutical companies in medical dermatology and aesthetic medicine, with landmark achievements including the U.S. and Canadian launches of iconic innovations such as Restylane®, Dysport®, and Solodyn®.